Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
Simon Paul PagetCaitlyn M SwinneyKaren L O BurtonKaren BauStephen J O'FlahertyPublished in: Developmental medicine and child neurology (2018)
Systemic adverse events occur in 3.6% of botulinum neurotoxin A (BoNT-A) injection episodes. Dysphagia and/or aspiration pneumonia are associated with increased likelihood of systemic adverse events. Multivariable models showed no evidence of association between Gross Motor Function Classification System and systemic adverse events. Multivariable models showed no evidence of association between BoNT-A dose and systemic adverse events.